Abstract:Aim: Liquid biopsies analyzing cell-free DNA (cfDNA) methylation in plasma offer a noninvasive diagnostic for diseases, with the potential of aging biomarkers underexplored. Methods: Utilizing enzymatic methyl-seq (EM-seq), this study assessed cfDNA methylation patterns in aging with blood from 35 healthy individuals. Results: It found aging signatures, including higher cfDNA levels and variations in fragment sizes, plus approximately 2000 age-related differentially methylated CpG sites. A biological age predictive model based on 48 CpG sites showed a strong correlation with chronological age, verified by two datasets. Age-specific epigenetic shifts linked to inflammation were revealed through differentially methylated regions profiling and Olink proteomics. Conclusion: These findings suggest cfDNA methylation as a potential aging biomarker and might exacerbate immunoinflammatory reactivity in older individuals. Our bodies undergo many changes as we age, some of which might affect our health. To better understand these changes, scientists study something called 'cell-free DNA' (cfDNA) in our blood. This cfDNA can give us clues about our health and the risk of diseases like cancer or heart conditions. In our research, we analyzed cfDNA from the blood of 35 people to identify patterns associated with aging. We discovered that approximately 2000 specific spots in our DNA change in a way that's linked to aging. These changes might help us figure out someone's biological age – essentially, how old their body seems based on various health factors, which can differ from their actual age. We also found that these DNA changes could indicate how aging might make the body's defense system – which fights off diseases – react more intensely. Understanding this could be crucial for managing health as we get older. Our study suggests that cfDNA could be a useful marker for aging, offering a new approach to understanding and possibly managing the health effects associated with growing older. A new study reveals cfDNA methylation in blood as a promising noninvasive marker for aging. Analysis of 35 individuals highlights key aging signatures and approximately 2000 age-related changes in DNA methylation, linking aging with inflammation. #AgingResearch #LiquidBiopsy.

Whole‐genome methylation analysis of aging human tissues identifies age‐related changes in developmental and neurological pathways

DNA methylation and healthy human aging

A comprehensive map of the aging blood methylome in humans

Age-related DNA Methylation Changes in Peripheral Whole Blood

An Integrative Multi-Scale Analysis of the Dynamic DNA Methylation Landscape in Aging.

DNA methylation correlates of chronological age in diverse human tissue types

Infrequent Occurrence of Age-Dependent Changes in CpG Island Methylation As Detected by Restriction Landmark Genome Scanning.

Genome-wide association studies identify 137 loci for DNA methylation biomarkers of ageing

Aging Effects on Dna Methylation Modules in Human Brain and Blood Tissue

Aging of blood can be tracked by DNA methylation changes at just three CpG sites

Modulation of DNA methylation by one-carbon metabolism: a milestone for healthy aging

Utility of DNA Methylation as a Biomarker in Aging and Alzheimer's Disease

Reduced DNA methylation patterning and transcriptional connectivity define human skin aging

Genome-Wide DNA Methylation Profile Indicates Potential Epigenetic Regulation of Aging in the Rhesus Macaque Thymus

DNA methylation age of blood predicts all-cause mortality in later life

Integrative epigenetics and transcriptomics identify aging genes in human blood

DNA methylation GrimAge version 2

Epigenome-Wide Scans Identify Differentially Methylated Regions for Age and Age-Related Phenotypes in A Healthy Ageing Population

Cell-free DNA methylation patterns in aging and their association with inflamm-aging

Gene body DNA hydroxymethylation restricts the magnitude of transcriptional changes during aging